If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBONH.L Regulatory News (BONH)

  • There is currently no data for BONH

Form 8 (OPD) (Bonhill Group plc)

12 Oct 2022 07:00

RNS Number : 5554C
Bonhill Group PLC
12 October 2022
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Bonhill Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Bonhill Group plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

10 October 2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares of 1 penny each in the Company

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

 

Nil

 

(2) Cash-settled derivatives:

 

Nil

 

Nil

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

 

Nil

 

 

TOTAL:

Nil

 

Nil

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

3(a) Interests held by the directors of Bonhill Group Plc and their close relatives and related trusts (excluding options and awards which are set out in 3(b) below):

 

Director

Position

Number of ordinary shares

Percentage of total issued ordinary share capital1

Jonathan Glasspool

Non-Executive Chairman

586,142

0.49

Patrick Ponsford

Group CEO

Nil

Nil

Sarah Thompson

Group CFO

Nil

Nil

Jonathan Kempster

Non-Executive Director

75,884

0.06

Laurie Benson

Non-Executive Director

53,792

0.05

Richard Staveley2

Non-Executive Director

Nil

Nil

1Based on 119,288,687 ordinary shares in issue.

2Richard Staveley is a board appointee of Harwood Capital LLP, the investment manager of Rockwood Strategic Plc, which holds 23,155,000 ordinary shares, being 19.41% of the Company's issued share capital.

 

3(b) Options and awards held by certain directors of Bonhill Group Plc in ordinary shares issued under the Bonhill Group 2018 Employee Share Option Plan:

 

 

 

 

 

Date of Grant

 

 

 

 

Name of option holder

Number of ordinary shares under outstanding options

 

 

 

 

Vesting Date

 

 

Expiry Date

 

 

 

Exercise Price (p)

26.10.20

Sarah Thompson (Group CFO)

1,000,000

27.10.23

26.10.30

1.0

26.10.20

Sarah Thompson (Group CFO)

1,000,000

27.10.24

26.10.30

1.0

26.10.20

Patrick Ponsford (Group CEO)

750,000

27.10.23

26.10.30

1.0

26.10.20

Patrick Ponsford (Group CEO)

750,000

27.10.24

26.10.30

1.0

07.10.22

Patrick Ponsford (Group CEO)

500,000

08.10.24

07.10.32

5.75

07.10.22

John French (Executive Director)

1,500,000

08.10.24

07.10.32

5.75

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

12 October 2022

Contact name:

Simon Bullock, Interim Group CFO 

Telephone number:

+44 (0) 20 3872 5749

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEEAPEFFFXAFFA
Date   Source Headline
20th Oct 20222:46 pmRNSForm 8.3 - Bonhill Group plc - Christopher Boxall
18th Oct 20224:39 pmRNSForm 8.3 - Bonhill Group PLC
13th Oct 20224:06 pmRNSForm 8.3 - Bonhill Group plc - Mark Horrocks
13th Oct 20223:01 pmRNSForm 8.3 - Bonhill Group plc - Simon Stilwell
12th Oct 20225:23 pmRNSForm 8.3 - Bonhill Group plc - Peter Tracey
12th Oct 20225:02 pmGNWForm 8.3 - Bonhill Group Plc
12th Oct 20221:43 pmRNSForm 8.3 - Bonhill Group plc - Anthony Cross
12th Oct 20229:49 amRNSForm 8.3 - Bonhill Group plc
12th Oct 20229:28 amGNWForm 8.5 (EPT/RI) - Bonhill Group Plc
12th Oct 20227:00 amRNSForm 8 (OPD) (Bonhill Group plc)
11th Oct 20221:51 pmRNSForm 8.3 - Bonhill Group Plc
11th Oct 202212:30 pmRNSForm 8.3 - Bonhill Group Plc
11th Oct 20229:13 amGNWForm 8.5 (EPT/RI) - Bonhill Group Plc
11th Oct 20227:00 amRNSHolding(s) in Company
10th Oct 20223:11 pmRNSForm 8.3 - Bonhill Group plc
10th Oct 202212:52 pmRNSForm 8.3 - Bonhill Group PLC
10th Oct 20227:01 amRNSTrading, Strategic Review & Formal Sale Process
10th Oct 20227:00 amRNSGrant of Incentives & Related Party Transaction
8th Sep 20227:00 amRNSHalf-year Report
26th Aug 20227:00 amRNSDisposal of BSG division
13th Jul 20227:00 amRNSDirectorate Changes
22nd Jun 20222:19 pmRNSResult of AGM
22nd Jun 20227:00 amRNSBusiness Disposal & Trading Update
9th Jun 20227:00 amRNSHolding(s) in Company
23rd May 20222:44 pmRNSHolding(s) in Company
19th May 20227:00 amRNSAvailability of Accounts and Notice of AGM
18th May 20227:00 amRNSHolding(s) in Company
16th May 20222:00 pmRNSHolding(s) in Company
11th May 202212:31 pmRNSResult of Open Offer, TVR & Directors’ Dealings
28th Apr 20227:00 amRNSHolding(s) in Company
25th Apr 20227:00 amRNSLaunch of Open Offer and Conditional Placing
22nd Apr 20224:16 pmRNSHolding(s) in Company
20th Apr 20227:01 amRNSFinal Results
20th Apr 20227:00 amRNSFirm Placing, Open Offer and Conditional Placing
7th Apr 20227:00 amRNSDirectorate changes, Fundraising & Trading Update
22nd Mar 20227:00 amRNSDate of Final Results
16th Feb 20227:00 amRNSDirector/PDMR Shareholding
25th Jan 20227:00 amRNSDirector/PDMR Shareholding
24th Jan 20227:00 amRNSDirector/PDMR Shareholding
18th Jan 20227:00 amRNSDirectorate Change
14th Jan 20227:00 amRNSTrading Update
20th Dec 20217:00 amRNSDirector/PDMR Shareholding
16th Dec 20217:00 amRNSDirectorate Change
26th Nov 20211:03 pmRNSTrading Statement
5th Nov 20217:00 amRNSSecond US PPP Loan Forgiven
8th Oct 202111:53 amRNSDirector/PDMR Shareholding
4th Oct 20211:28 pmRNSDirector/PDMR Shareholding
28th Sep 20217:42 amRNSDirector/PDMR Shareholding
14th Sep 20217:01 amRNSDirectorate Change
14th Sep 20217:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.